Many patients considering weight loss surgery in Ireland focus, understandably, on what happens in the first year. The weight loss is rapid, the changes are visible, and the impact on energy and health is often transformative. But the question I always want patients to think about is a longer one: what does this look like in ten years?

https://blackrockweightcare.ie/weight-loss-surgery-dublinThe answer, based on decades of high-quality evidence, is one of the most compelling stories in modern medicine. Bariatric surgery is not just about weight. It is about adding years to your life, reducing your risk of cardiovascular disease, cancer, and diabetes, and sustaining those benefits for the long term — not for months, but for decades.

Here is what the evidence actually shows.

The Big Picture: What 20 Years of Data Tells Us

The most authoritative long-term evidence comes from the Swedish Obese Subjects (SOS) study — a landmark prospective study that enrolled over 4,000 patients with obesity from 1987 to 2001 and followed them for up to 20 years. It remains the most comprehensive long-term investigation of bariatric surgery ever conducted.

Evidence · New England Journal of Medicine, 2020 — SOS Study

The SOS study found that, over 20 years of follow-up, patients who had bariatric surgery had an adjusted median life expectancy approximately 3 years longer than matched controls receiving usual obesity care. The hazard ratio for overall mortality was 0.77 — a 23% reduction. Cardiovascular mortality was reduced by 30%. The 90-day postoperative mortality in the surgical group was 0.2%.

These are not small improvements. A 3-year gain in life expectancy from a single intervention is a result that rivals many of the most celebrated treatments in cardiovascular medicine. And unlike medication, the effect does not stop when you stop taking something – because there is nothing to stop taking.

Year by Year: What to Expect

Year 1 — Rapid Transformation

The first year typically sees the most dramatic change. Most patients experience their fastest rate of weight loss in months 1–12.

• Average total body weight loss of 25–35% in the first year depending on procedure
• Type 2 diabetes improves or resolves — often within weeks of surgery, before major weight loss
• Blood pressure, sleep apnoea and joint pain typically improve significantly
• Energy levels, mobility and quality of life improve substantially

Years 2–5 — Consolidation

Weight loss typically slows and stabilises after the first 12–18 months. Some degree of weight regain is normal and expected in most patients — this does not represent failure.

• SOS study: mean weight loss of 23% at 2 years, stabilising to approximately 17% at 10 years
• Comorbidity resolution sustained — diabetes remission maintained in the majority
• The SLEEVEPASS trial (JAMA Surgery, 2022) confirmed sustainable weight loss for both sleeve and bypass at 10 years
• Cardiovascular risk factors continue to improve relative to non-surgical controls

Years 5–10 — Long-Term Durability

The defining period for durability. This is where bariatric surgery’s advantage over medication becomes most stark — medically-managed weight loss almost universally returns without ongoing treatment. Surgically-achieved weight loss largely persists.

• A systematic review and meta-analysis (O’Brien et al., Obesity Surgery, 2019) covering 57 datasets found all major bariatric procedures associated with durable weight loss at 10+ years
• Greater than 50% excess weight loss maintained for all current procedures at 10 years in the meta-analysis
• Mortality benefit becomes clearly established — SOS data shows advantage emerging over 10–13 years of follow-up
• Reduced incidence of myocardial infarction (adjusted HR 0.71) and stroke (adjusted HR 0.66) vs controls

15 Years and Beyond

The most compelling long-term data. Very few medical interventions for chronic disease can show benefits at this timeframe.

• SOS study: mean weight change of −16% at 15 years and −18% at 20 years in surgical group; essentially 0% in controls
• Cancer incidence reduced by 42% in women in the surgical group in the SOS study (men: no statistically significant difference)
• Life expectancy benefit sustained across all follow-up periods studied
• Patients with diabetes who achieved remission showed further reduction in long-term mortality risk

What About Weight Regain?

This is a question I encourage every patient to raise — because it deserves an honest answer. Some degree of weight regain after bariatric surgery is common and well-documented. It does not mean the surgery has failed, and it does not erase the benefits.

The SOS study data shows that even accounting for partial weight regain over time, surgical patients maintained substantially greater weight loss than non-surgical controls at every time point measured — 2, 10, 15 and 20 years. The cardiovascular and mortality benefits persisted regardless of the degree of regain.

Where significant weight regain does occur, we now have additional tools — including GLP-1 medication used as an adjunct — to help patients get back on track. This is part of what makes a comprehensive aftercare programme so important.

Beyond Weight: The Broader Health Benefits

Framing bariatric surgery purely as a weight loss procedure understates what it does. The most profound effects are often on conditions that carry the greatest health risk:

SOS Study · Summary of Key Outcomes at 10–20 Years

Type 2 diabetes: 83% reduction in new diagnoses; significant remission in those already diagnosed. Myocardial infarction: adjusted HR 0.71 (29% reduction). Stroke: adjusted HR 0.66 (34% reduction). Cancer (women): adjusted HR 0.58 (42% reduction). Overall mortality: adjusted HR 0.71–0.77 across follow-up periods. These outcomes are from published, peer-reviewed data in the New England Journal of Medicine and Journal of Internal Medicine.

These are not surrogate markers. These are deaths prevented, heart attacks avoided, and cancers that did not develop. The surgery that patients often fear most turns out to be one of the most powerful protective interventions available to people living with severe obesity.

Your Health. We Care.

The post What Does Bariatric Surgery Look Like after 5, 10 and 15 Years? appeared first on Blackrock WeightCare.

It is the frustration of someone who has watched obesity move through their family for years.

A mother who developed type 2 diabetes in her forties.
A father who struggled with weight and heart disease.
Siblings who are now facing the same pattern.

When that history is there, weight gain does not feel random. It feels inherited.

And many patients quietly ask the same question.

If this is in my genes, what chance do I really have?

The Role of Genetics in Obesity

Obesity is not simply the result of eating too much or moving too little. Modern research is clear that body weight is strongly influenced by biology. In fact, genetic factors can account for a significant proportion of a person’s tendency to gain weight.

Certain inherited traits affect how the brain regulates hunger and fullness. Some people feel satisfied quickly after a meal. Others feel persistent hunger even when they have eaten adequately. Some individuals burn energy more efficiently. Others store energy more readily.

When obesity runs in families, it is often because these biological signals are shared.

This is why two people can follow similar diets and exercise routines, yet experience very different results. One may lose weight steadily. The other may struggle constantly, losing and regaining weight despite genuine effort.

It is not a character flaw. It is physiology.

Why Weight Regain Is So Common

For patients with hereditary obesity, the body often defends its weight very aggressively.

When weight is lost through calorie restriction alone, the brain responds by increasing hunger hormones and reducing metabolic rate. The body interprets weight loss as a threat. It works to restore what has been lost.

If you are genetically predisposed, that response can be stronger and longer lasting.

This is why so many people describe years of dieting followed by regain. Over time, the cycle becomes exhausting. Confidence drops. Shame creeps in. And yet the underlying biology has never truly been addressed.

The Link With Diabetes and Other Conditions

Genetic obesity rarely exists in isolation. It is frequently associated with:

• Type 2 diabete
• High blood pressure
• Sleep apnoea
• Fatty liver disease
• Cardiovascular risk

In Ireland, we are seeing younger patients developing metabolic disease earlier than previous generations. A strong family history of diabetes or heart disease should not be ignored.

Obesity is not simply about weight. It is about long-term health risk.

Where Do Medications Like Ozempic and Mounjaro Fit

Treatments such as Ozempic and Mounjaro have changed how we approach obesity management. These medications act on gut hormones that regulate appetite and blood sugar. For many patients, they reduce constant hunger and make portion control achievable for the first time.

For individuals with moderate obesity, particularly those with early type 2 diabetes, these treatments can be very effective. They can reduce weight, improve HbA1c, and lower cardiovascular risk.

But for patients with severe obesity — particularly BMI over 40 or over 35 with significant medical complications — medication alone may not provide enough metabolic change to reverse established disease.

That does not mean medication has failed. It simply means the severity of the condition may require a more powerful intervention.

How Bariatric Surgery Addresses the Underlying Biology

Bariatric surgery, including gastric sleeve, gastric bypass and SADI-S, works at a deeper hormonal level.

It changes the communication between the gut and the brain. Hunger signals are reduced. Satiety improves. Insulin sensitivity increases. In many cases, blood sugar levels normalise rapidly after surgery, even before significant weight loss occurs.

For patients with hereditary obesity, this hormonal shift can counteract the biological drivers that have made weight control so difficult.

This is why bariatric surgery remains the most effective treatment for severe obesity and obesity-related type 2 diabetes. Long-term studies show sustained weight loss, high rates of diabetes remission and meaningful reductions in cardiovascular risk.

In Ireland and the UK, bariatric surgery is recognised as a medically necessary treatment for appropriate patients — not a cosmetic procedure.

Breaking a Pattern That Feels Inevitable

One of the most powerful moments in consultation is when a patient realises that their story does not have to follow the same path as their parents’.

If a parent required insulin in their fifties, that does not mean the same outcome is unavoidable.

If heart disease developed early in one generation, intervention can change the risk in the next.

Treating obesity effectively is not only about today. It is about reducing the likelihood of kidney disease, stroke, heart attack and mobility loss in the years ahead.

When obesity is genetic, early and appropriate treatment matters even more.

So Can Bariatric Surgery Help If Obesity Is Genetic

Yes. It can.

It does not erase your genes. But it can significantly reduce their impact.

For patients with severe or complex obesity, particularly those with a strong family history of metabolic disease, bariatric surgery offers the most durable improvement in weight, diabetes control and overall health risk.

The decision is never rushed. Assessment is careful. Medical treatment, including weight loss injections, may still have a role before or after surgery.

The goal is not simply weight reduction. The goal is long-term metabolic health.

You Are Not Alone In This

If obesity runs in your family and you feel that you have tried everything, it is important to understand that your experience is valid.

You may not lack discipline. You may be living with a chronic, genetically influenced disease that requires medical and possibly surgical care.

At Blackrock WeightCare, based at the Blackrock Clinic, we provide comprehensive obesity treatment including medical weight management and advanced bariatric surgery. Each patient is assessed individually, with careful consideration of family history, metabolic health and long-term goals.

If you would like to explore your options, you can begin by filling out a form on our website here or speak directly with our team on 01 255 2479.

Your Health. We Care.

The post Is Obesity Genetic, and Can Bariatric Surgery Help appeared first on Blackrock WeightCare.

If you are considering weight loss surgery in Ireland, one question comes up in almost every consultation: should I have the sleeve or the bypass?

It is the right question to ask. Both procedures are highly effective, both are proven to produce durable weight loss, and both are available at Blackrock WeightCare using Ireland’s first robotic bariatric surgery programme. But they work differently, suit different patients, and come with different long-term considerations.

There is no universal answer. But there is a best answer for you – and this guide will help you understand what that might be.

How Each Procedure Works

Gastric Sleeve (Sleeve Gastrectomy)

The stomach is permanently reduced to roughly 20% of its original size — forming a narrow, sleeve-shaped tube. This limits how much food you can eat and, critically, removes the portion of the stomach that produces most of the hunger hormone ghrelin. The result is that patients feel full faster and feel less hungry overall. There is no rerouting of the digestive system.

Gastric Bypass (Roux-en-Y Gastric Bypass)

A small stomach pouch is created at the top of the stomach, and the small intestine is rerouted to connect to it directly – bypassing the remainder of the stomach and the upper section of the small bowel. Food passes through a shorter digestive route. This produces powerful changes in gut hormones, and has particularly strong effects on conditions like type 2 diabetes, often producing remission before significant weight loss has even occurred.

How They Compare: The Evidence

Evidence · Lancet Diabetes & Endocrinology, 2025

The Oseberg trial — a long-term randomised controlled trial — found that gastric bypass was superior to sleeve gastrectomy for remission of type 2 diabetes at 5 years, with bypass patients more than twice as likely to achieve remission. Bypass also produced greater total weight loss and better outcomes for LDL cholesterol. The SleeveBypass trial (Lancet Regional Health, 2024) found the two procedures produced clinically comparable excess BMI loss at 5 years, though bypass showed advantages in total weight loss and cholesterol outcomes.

Who Is Each Procedure Best For?

Gastric Sleeve – Gastric Sleeve tends to suit patients who have no significant acid reflux, are looking for a technically simpler procedure, have a lower BMI range for surgery, do not have type 2 diabetes or have well-controlled diabetes, or wish to minimise the risk of nutritional complications.

Gastric Bypass – Gastric Bypass tends to suit patients who have type 2 diabetes or pre-diabetes, have significant acid reflux or GERD, have a higher BMI, have had a sleeve gastrectomy that produced insufficient weight loss, or where maximum metabolic benefit is the primary clinical goal.

It is important to be honest: these are guides, not rules. Individual anatomy, comorbidities, previous surgical history, and personal circumstances all factor into the recommendation. This is precisely why a thorough pre-operative assessment — including consultation with a dietitian, physician, and psychologist — is essential before any decision is made.

The landmark Swedish Obese Subjects (SOS) study — which followed over 4,000 patients for up to 20 years — found that bariatric surgery was associated with a 23% reduction in overall mortality compared to matched controls receiving usual care, and a 30% reduction in cardiovascular mortality. Surgery adds years to life. Both procedures share in this benefit.

A Note on Robotic Surgery

At Blackrock WeightCare, both sleeve gastrectomy and gastric bypass are available using Ireland’s first robotic bariatric surgery programme. Robotic-assisted surgery allows greater precision, improved visualisation, and can be particularly advantageous for patients with higher BMI or more complex anatomy. Mr Robb will advise at the consultation whether the robotic or laparoscopic technique is most appropriate for your procedure.

Your Health. We Care.

The post Gastric Sleeve vs Gastric Bypass: Which is Right for You? appeared first on Blackrock WeightCare.

The medical community’s understanding of obesity has undergone a significant evolution. Where it was once viewed primarily as a lifestyle issue — a comorbidity arising from poor choices — it is now increasingly classified as a chronic, progressive disease in its own right. This is not merely a semantic change. It has profound implications for how patients are assessed, counselled, and treated.

Obesity is now understood to be associated with more than 200 distinct health conditions. More significantly, it is no longer viewed as a consequence of those conditions — it is increasingly recognised as a driver of them. Adipose tissue, long dismissed as passive calorie storage, is now known to function as a highly active endocrine organ, secreting pro-inflammatory cytokines and metabolic mediators that exert systemic effects on the cardiovascular, hepatic, and renal systems.

“Obesity is not simply excess weight — it is a state of chronic biological dysfunction that reshapes the disease trajectory of multiple organ systems simultaneously.“

The Role of Visceral Adiposity

Not all fat is metabolically equivalent. At a healthy weight, the majority of adipose tissue is stored subcutaneously, where it functions as a relatively inert energy reserve. As fat mass increases, the body’s capacity for safe subcutaneous storage becomes overwhelmed, and lipid deposition shifts to visceral compartments — surrounding the liver, kidneys and heart.

Visceral adipose tissue is considerably more metabolically active than its subcutaneous counterpart. It exhibits higher lipolytic activity, generates excess free fatty acids, and produces pro-inflammatory mediators that enter the portal circulation directly. The downstream consequences — hepatic steatosis, insulin resistance, systemic inflammation, and accelerated cardiovascular risk — are well documented.

Genetic studies further suggest that individuals predisposed to visceral rather than subcutaneous fat storage carry a substantially elevated cardiometabolic risk profile, independent of total body weight.

Why Treatment Must Be Matched to the Individual

The emergence of GLP-1 receptor agonists has transformed the medical management of obesity, offering clinically meaningful weight reduction and cardiovascular benefit for many patients. However, the evidence is clear that these agents do not work uniformly. Approximately one in four patients with obesity does not achieve clinically significant weight loss with GLP-1 therapy alone — underscoring the heterogeneity of the condition and the need for a stratified treatment approach.

Bariatric surgery remains the most effective and durable intervention available for patients with severe obesity or those with significant metabolic comorbidities. Its benefits extend well beyond weight reduction: improvements in glycaemic control, blood pressure, hepatic steatosis, and cardiovascular risk are well established, and in many cases precede significant weight loss — suggesting mechanisms of action that go beyond caloric restriction alone.

The Diagnosis Gap — and Why Early Referral Matters

A further challenge is the persistent under-diagnosis of obesity in clinical practice. Recent data suggests that approximately 30% of individuals meeting the BMI threshold for obesity do not have a formal obesity diagnosis recorded. Earlier identification creates earlier opportunity — to intervene before comorbidities develop or compound, and to match patients to the treatment pathway most likely to be effective for their individual biology.

Blackrock WeightCare – Specialist Obesity Care in Dublin

Blackrock WeightCare provides comprehensive, evidence-based obesity treatment at the Blackrock Clinic. Our service offers bariatric surgical assessment and intervention, medical obesity management including GLP-1 therapies, and structured multidisciplinary follow-up – with a shared goal of delivering meaningful, sustained improvements in both weight and metabolic health.

For GPs considering referral, or for patients seeking specialist assessment, we welcome enquiries through our website. The right treatment, delivered at the right time, can change the long-term health trajectory of patients living with obesity.

Referring a patient or seeking a specialist consultation? We’d be glad to hear from you – 01 255 2479.

Your Health. We Care.

The post Obesity is a Disease of Biology, Not Behaviour – What the Latest Science Means for Treatment appeared first on Blackrock WeightCare.

If you have tried – really tried – to lose weight and found it almost impossible to keep off, there is something important you need to hear: your body is actively working against you. Not because you lack discipline. Not because you are not trying hard enough. But because of the way human biology is wired. 

New research is fundamentally changing how medicine understands obesity. Far from being a simple matter of eating less and moving more, obesity is now recognised as a chronic, systemic condition – one that involves the brain, the gut, the liver, the heart, and a remarkable organ most of us have never thought much about: fat tissue itself.

“Obesity is not a reflection of character. It is a biological condition – and like all biological conditions, it deserves proper medical treatment.”

Fat Tissue: The Hidden Organ Driving Your Health 

Most people think of body fat as inert – a passive store of excess calories. In reality, fat tissue is one of the most metabolically active organs in the body. It produces hormones, generates inflammatory signals, and communicates constantly with the brain and other organs. When fat accumulates in the wrong places – particularly around the abdominal organs – it stops functioning as a safe reservoir and starts actively disrupting the body’s normal processes.

This is why obesity is associated with so many seemingly unrelated health conditions: heart disease, type 2 diabetes, liver disease, joint problems, sleep apnoea, and even depression. It is not a coincidence – it is biology. The excess fat is driving inflammation and dysfunction throughout the body, often long before symptoms become obvious.

Why the Weight Comes Back

One of the most important and least talked about aspects of obesity is what happens when you lose weight. The body interprets any significant fat loss as a threat to survival. In response, it increases hunger hormones, reduces metabolic rate, and creates powerful cravings designed to bring your weight back up. This is not a lack of willpower. It is a deeply ingrained survival mechanism that has been shaped by millions of years of evolution.

This is also why short-term diets almost always fail in the long run, and why people often feel worse – more hungry, more obsessed with food – after losing weight than before. The body has shifted into defence mode.

There is No Single Solution – And That’s Why Expert Care Matters

Medical treatments for obesity have improved enormously in recent years. GLP-1 medications have helped many people achieve meaningful weight loss. But they don’t work for everyone – studies suggest up to a quarter of patients don’t achieve clinically significant results with medication alone. For others, bariatric surgery offers the most effective and durable long-term outcomes available.

The key is matching the right treatment to the right person – taking into account your individual biology, medical history, and goals. That is precisely what a specialist obesity service does.

Getting the Right Help in Dublin

At Blackrock WeightCare, based at the Blackrock Clinic, we take a comprehensive, evidence-based approach to obesity treatment. Whether your path involves medical management, bariatric surgery, or a combination of both, our team will work with you to build a treatment plan that fits your life – not a one-size-fits-all protocol.

If you have been struggling with your weight and feel you have run out of options, you have not. You may simply not yet have had access to the right support.

You can begin the conversation by visiting our contact page or speak directly with our team on 01 255 2479.

Your Health. We Care.

The post Why Losing Weight Is So Hard – And Why It’s Not About Willpower appeared first on Blackrock WeightCare.

Mr William Robb, Consultant Bariatric and Upper Gastrointestinal Surgeon at Blackrock WeightCare, has consistently emphasised that revision surgery should not be viewed as failure. Obesity is a chronic, relapsing disease. Surgical intervention is powerful, but long-term disease progression, anatomical factors and evolving metabolic challenges may require reassessment.

Understanding revision bariatric surgery

Revision bariatric surgery refers to a secondary procedure performed after a previous weight loss operation. This may involve:

• Conversion of one procedure to another
• Correction of anatomical complications
• Surgical management of inadequate weight loss or weight regain
• Treatment of severe reflux or nutritional complications

Revision surgery is technically more complex than primary bariatric surgery and should be undertaken in experienced, high-volume centres.

When should GPs consider referral?

There are several clear clinical scenarios where referral for specialist reassessment is appropriate.

1. Significant weight regain

Some degree of weight regain can occur several years after bariatric surgery and does not automatically indicate surgical failure. However, substantial regain — particularly when accompanied by recurrence of comorbidities such as type 2 diabetes, hypertension or obstructive sleep apnoea – warrants specialist review.

In clinical practice, revision referrals most commonly follow sleeve gastrectomy. While sleeve surgery is highly effective for many patients, a subset may experience weight regain over time or develop anatomical changes such as sleeve dilation. In selected cases, conversion to another metabolic procedure may restore weight control and improve metabolic outcomes.

GPs should consider referral when:

• BMI rises significantly above the patient’s post-operative low
• Glycaemic control deteriorates after a period of remission
• Antihypertensive or diabetic medication burden begins to increase again

Early referral allows structured reassessment, including dietary review, behavioural factors, metabolic evaluation and, where appropriate, imaging to assess anatomy.

2. Inadequate initial weight loss

A small proportion of patients may not achieve expected weight loss following primary surgery. This is again most frequently seen after sleeve gastrectomy, particularly in patients who began with higher BMI or severe metabolic disease.

In these cases, referral allows consideration of whether escalation to a more metabolically powerful procedure — such as gastric bypass or SADI-S — may be appropriate.

3. Persistent or severe reflux after sleeve gastrectomy

Gastro-oesophageal reflux disease is a recognised complication following sleeve surgery. Persistent reflux symptoms despite optimal medical therapy should prompt surgical evaluation.

Conversion from sleeve gastrectomy to gastric bypass is an established revisional strategy and can offer significant symptomatic relief in carefully selected patients.

Referral is appropriate when:

• Reflux remains uncontrolled despite proton pump inhibitors
• Endoscopic evidence of oesophagitis is present
• Barrett’s oesophagus develops or progresses

4. Complex or high BMI patients

Patients who began with BMI over 50, or those with severe metabolic disease, may occasionally require further intervention if initial weight loss has been insufficient.

Revisional bariatric surgery in these cases is technically complex and should be undertaken in experienced, high-volume centres with advanced minimally invasive or robotic capability.

Why experience matters in revision surgery

Revision bariatric surgery is inherently more complex than primary procedures. Previous surgery alters anatomy, creates adhesions and may change tissue planes. These factors require careful pre-operative planning and precise intraoperative technique.

Nutritional status, metabolic stability and psychological readiness must also be reassessed. Revision surgery is not simply a technical adjustment – it is a structured re-evaluation of a chronic disease pathway.

For this reason, revisional procedures are best undertaken in experienced, high-volume centres with advanced minimally invasive and robotic capability. Enhanced visualisation and instrument precision can be particularly valuable in complex cases where anatomy has already been modified.

Careful case selection, multidisciplinary discussion and structured follow-up remain central to safe and effective revision practice.

A collaborative approach with primary care

GPs play a pivotal role in long-term follow-up after bariatric surgery. Monitoring weight trajectory, glycaemic control, blood pressure and symptom progression allows early identification of patients who may benefit from reassessment.

Referral for revision surgery should not be interpreted as treatment failure. Obesity is a chronic metabolic condition. Disease progression, anatomical adaptation or evolving comorbidities may require adjustment of the original strategy.

At Blackrock WeightCare, referrals for revision assessment are welcomed via Healthlink. Each patient undergoes detailed review of previous operative history, current metabolic status, symptom profile and long-term goals before any recommendation is made.

The aim is always to restore metabolic control safely and appropriately.

Supporting your patients at the right time

GPs remain central to long-term care after bariatric surgery. When weight regain, relapse of diabetes or persistent reflux becomes apparent, early referral for reassessment can help prevent further progression.

Revision surgery is not about repeating the past, it is about adjusting the treatment pathway where needed.

At Blackrock WeightCare, every referral is reviewed carefully and individually. GPs can refer via Healthlink or contact the team directly to discuss a patient – 01 255 2479.

Your Health. We Care.

The post When should GPs consider referral for revision bariatric surgery appeared first on Blackrock WeightCare.

That’s the wrong question.

The right question is: what does this patient need, at this stage of their disease?

Obesity is chronic, progressive, and heterogeneous. The era of picking a lane — medical or surgical — is over. The best outcomes come from building integrated pathways. Here’s how I think we could think about it clinically.

BMI 27–35: Early intervention, metabolic protection

This is where the newer incretin therapies have genuinely expanded our toolkit. For patients without advanced complications, GLP-1s can achieve meaningful weight loss and delay progression to T2DM, NAFLD, and OSA. The goal here is prevention — getting in early before the disease accumulates damage. Medication earns its place at this stage, and I use it.

BMI 35–45: The judgment zone

No dogma here. This is where clinical decision making meets outcome data.

I’ll consider GLP-1s alone when diabetes is mild or very recently diagnosed and the patient is highly adherent. Endoscopic options when they want a lower-risk bridge with 15% total body weight loss (TBWL). Surgery when there’s severe GERD, significant visceral fat, liver fibrosis, established diabetes or a poor response to medical therapy.

Often the sequence is: surgery for the durability that drugs alone haven’t matched long-term. HbA1c, reflux burden, functional status, and what the patient can realistically sustain for 20 years, cumulative cost of injectables — these also can drive the decision for surgery versus a trial of medication, not the BMI alone.

BMI 45+: Surgery anchors the pathway

The data here hasn’t changed, and it won’t be overturned by a few years of GLP-1 trial data. For severe obesity with end-organ damage — fatty liver disease, refractory T2DM, sleep apnoea, joint destruction — metabolic surgery delivers weight loss and disease remission at a magnitude we cannot replicate pharmacologically with medications available to date. Not yet. Possibly not ever, for this cohort.

That said, GLP-1s have earned a genuine role around surgery: shrinking the liver pre-operatively in very high BMI patients, reducing anaesthetic risk, and rescuing for weight regain long after the operation. They can extend what surgery starts. They don’t replace what surgery does.

What the best programs are building

Stratify by more than BMI — we need to stratify patients by metabolic burden, genetics, psychological readiness, and social context all matter. Sequence therapies deliberately and consider what the correct combinations are based on the stage of the disease. Follow patients for decades, not months. And put surgeons, physicians, dietitians, and psychologists in the same room, sharing the same data.

The tribalism between “medical” and “surgical” camps has cost patients. The win here is designing systems that deliver the right option, to the right patient, at the right moment in their disease trajectory.

That’s precision obesity care. And it needs surgeons to build it.

Your Health. We Care.

The post Knife and Needles appeared first on Blackrock WeightCare.

Will the weight come back?

The honest answer is that weight regain can happen with both treatments. The difference lies in why it happens, how common it is, and how it is managed.

Understanding that difference matters before choosing your next step.

Why Weight Regain Happens After Injections

Medications such as Mounjaro and Ozempic work by regulating appetite hormones and slowing stomach emptying. While you are taking them, appetite is reduced and calorie intake falls.

The challenge is what happens when the medication stops.

These injections do not permanently change the anatomy of the digestive system. Once the medication is withdrawn:

• Appetite hormones gradually return to baseline
• Hunger increases
• Calorie intake rises
• Weight regain can occur

Clinical studies have shown that a significant proportion of weight lost on GLP-1 medications may be regained after stopping treatment if no structured long-term plan is in place.

This means injections need to be continued long term to maintain results. Medication is a lifelong treatment for a chronic disease. That carries a commitment to continuing the medications with clear cost implications and requires ongoing medical supervision.

Why Weight Regain Happens After Bariatric Surgery

Weight regain after surgery is different.

Procedures such as Gastric Sleeve and SADI-S permanently alter stomach size and, in some cases, nutrient absorption. They also create long-lasting hormonal changes that reduce hunger and improve insulin sensitivity.

However, surgery is not immune to weight regain.

Reasons may include:

• Gradual adaptation of the stomach over time
• High-calorie liquid intake
• Grazing behaviour
• Emotional eating
• Reduced follow-up engagement
• Lack of dietary structure

The key difference is that the anatomical and hormonal changes from surgery remain in place. This makes weight regain generally slower and often less dramatic than after stopping injections.

In most cases, surgery provides more durable long-term weight loss, particularly in patients with BMI over 45.

How Much Weight Regain Is Normal

After bariatric surgery, small amounts of weight regain several years later can be normal. The body stabilises after the initial weight loss phase. The goal is not zero regain. The goal is maintaining significant net weight loss and improvement in health.

After stopping injections, weight regain can be more rapid because the hormonal effect is removed entirely.

The pattern is different. The underlying biology explains why.

Which Offers More Durable Results

For patients with severe obesity, especially BMI above 40, bariatric surgery consistently shows stronger and more durable long-term outcomes compared to injections alone.

Injections can be effective for moderate obesity. They are valuable tools. But they do not currently match the long-term metabolic impact of surgery in higher BMI groups. That does not mean injections have no role. In some patients, they are appropriate as:

• A primary treatment
• A bridge before surgery
• Support in cases of mild post-surgical regain

For many patients the treatment of their obesity may involve both – often surgery now and medication later if ever required.

The decision depends on the individual.

What Happens if Weight Regain Occurs

At Blackrock WeightCare, weight regain is managed proactively.

This may include:

• Nutritional review
• Behavioural support
• Medical optimisation
• Use of medication where appropriate
• Consideration of revisional surgery in selected cases

Mr William Robb assesses each situation carefully. As an Upper GI and Robotic Bariatric Surgeon, he evaluates anatomical, metabolic and behavioural factors before recommending next steps.

The focus is always on long-term health, not short-term numbers.

The Bigger Question

The real question is not whether weight regain is possible. It is which treatment offers the most sustainable control of a chronic disease.

Obesity is a long term chronic disease. It requires a long-term plan and an ever evolving algorithm of care.

Injections require ongoing use to maintain effect. Surgery creates permanent anatomical and hormonal changes that support durability, particularly in higher BMI patients.

Neither is a quick fix. Both require commitment and follow-up.

Choosing the Right Path

If you are concerned about weight regain, whether after injections or surgery, the right step is expert assessment before making changes.

At Blackrock WeightCare, complex and high BMI patients are routinely assessed to determine the safest and most effective long-term strategy.

To know more, click here and fill the enquiry form or speak directly with our team on 01 255 2479.

Your Health. We Care.

The post Weight Regain After Injections vs Bariatric Surgery: What is the Difference appeared first on Blackrock WeightCare.

A common concern we hear is this – Do I need to lose weight with injections first before I can be considered for bariatric surgery?

In many cases, the answer is ‘No’.

You Do Not Always Need Injections Before Surgery

Patients with BMI above 45, and particularly those above 50, are sometimes told they must reduce weight before surgery is even discussed. This can lead to months or even years spent trying medications first.

At Blackrock WeightCare, we regularly assess and treat high BMI and complex cases. Surgery is not automatically ruled out because your BMI is high. In fact, procedures such as SADI-S are specifically designed for patients who require a stronger metabolic effect.

If surgery is clinically appropriate, it can be planned safely without asking you to invest time and money into injections first.

Each case is assessed on its own merits.

When Injections May Be Helpful

That said, weight loss injections can sometimes be useful.

They may help:

• Improve blood sugar control before surgery
• Reduce liver size
• Optimise medical conditions
• Support short-term weight reduction in selected cases

But this is strategic and individual. It is not a requirement for everyone.

Injections should never be viewed as a mandatory first step before surgical assessment.

High BMI Is Not an Automatic Barrier

Severe obesity often comes with additional conditions such as Type 2 diabetes, sleep apnoea, joint disease or cardiovascular risk. These patients need specialist input, not delay.

At Blackrock WeightCare, complex and high BMI patients are routinely assessed by Mr William Robb, an experienced Upper GI and Robotic Bariatric Surgeon. Careful evaluation determines:

• Whether surgery is safe now
• Whether optimisation is required first
• Which procedure offers the best long-term outcome

In many cases, metabolic surgery such as Gastric Sleeve or SADI-S provides more durable weight loss and stronger metabolic improvement than injections alone.

Why Expert Assessment Matters First

Starting injections without specialist advice can lead to:

• Modest short-term weight loss but no long-term plan
• Weight regain after stopping medication
• Delayed definitive treatment
• Additional financial cost

Obesity is a chronic disease. The treatment pathway should be planned properly from the outset.

An expert consultation allows you to understand:

• Whether injections are appropriate
• Whether surgery is the more effective option
• Whether a combined approach makes sense
• What is safest given your BMI and medical history

The right decision depends on your health, not on trends.

The Bottom Line

Weight loss injections can play a really positive role in obesity treatment. They are very useful tools in well selected and educated patients.

But you do not need to “prove yourself” with injections before being considered for surgery.

If you have a high BMI or complex medical history, the first step should always be specialist assessment. That way, you avoid unnecessary delay and move forward with a clear plan. Surgery and medication are very often complementary in the treatment of obesity – rather than it being the case of one or the other. 

If you would like to discuss your options, you can enquire here or speak directly with our team on 01 255 2479.

Your Health. We Care.

The post Can Weight Loss Injections Help You Qualify for Surgery appeared first on Blackrock WeightCare.

SADI-S is one of the more powerful bariatric procedures available and is designed for people with severe obesity who need more than a standard sleeve alone.

What SADI-S Means in Practical Terms

SADI-S combines a sleeve gastrectomy with a bypass of part of the small intestine. The stomach is reduced in size, and food passes further down the intestine, which creates a strong metabolic effect.

This tends to result in:

• Greater overall weight loss in higher BMI patients
• Strong improvement in blood sugar control
• Reduction in cardiovascular risk factors
• Better long-term outcomes in patients with BMI above 45

The procedure is carried out by Mr William Robb using advanced robotic and minimally invasive surgical techniques, with a focus on precision and patient safety.

Who is it Suitable For

SADI-S is generally considered for:

• Patients with BMI over 45
• Severe obesity with significant metabolic disease
• Poorly controlled Type 2 diabetes
• Patients who require substantial and sustained weight loss

This is not a routine operation for lower BMI ranges. It is chosen carefully, based on clinical need and long-term goals.

What to Expect Before Surgery

The preparation is thorough. You can expect:

• A detailed surgical consultation
• Full medical assessment and blood tests
• Review of medications and current health conditions
• A structured pre-operative diet plan
• Clear explanation of risks and long-term responsibilities

An important part of the process is psychological evaluation. This is not a test to pass or fail. It is there to ensure you are emotionally prepared for the changes ahead. Surgery alters eating patterns, routines and coping mechanisms. Understanding your relationship with food, stress and lifestyle habits helps build a safer and more sustainable outcome.

This step is about support, not judgement.

What to Expect Around the Time of Surgery

SADI-S is carried out under general anaesthesia. Most patients stay in the hospital for 1-2 days.

After surgery, you can expect:

• Early mobilisation
• A gradual transition from liquids to soft foods
• Smaller portion sizes
• Rapid early weight loss
• Regular contact with the clinical team

The first few weeks require adjustment. Energy levels can fluctuate as your body adapts.

What to Expect in the Months After

Weight loss usually progresses steadily over 12 to 24 months. Many patients experience:

• Significant total body weight loss
• Improved diabetes control, sometimes with reduced medication
• Lower blood pressure
• Less joint pain
• Improved sleep quality
• Greater mobility

Results vary, but meaningful health improvement is the goal.

Because part of the intestine is bypassed, lifelong vitamin and mineral supplementation is required. Regular blood monitoring forms part of follow-up care. The structured aftercare programme at Blackrock WeightCare supports patients for the long term, not just the immediate post-operative period.

Accessing SADI-S Surgery in Ireland for High BMI Patients from Northern Ireland

Patients in Northern Ireland with very high BMI can face limited access to advanced bariatric procedures or long waiting times. Choosing treatment in Dublin at Blackrock WeightCare allows surgery and follow-up to take place within Ireland, with regular communication with your GP and ongoing monitoring close to home.

Many patients prefer this to travelling abroad, where long-term follow-up and nutritional supervision can be difficult to maintain.

SADI-S is a serious decision. It requires commitment and follow-through. It is also one of the most effective tools available for treating severe obesity and its related conditions.

If you would like to explore whether SADI-S is suitable for you, you can enquire through our website or speak directly with our team on 01 255 2479.

Your Health. We Care.

The post What to Expect if You Are Considering SADI-S Surgery appeared first on Blackrock WeightCare.